These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29096547)

  • 41. Magnetic resonance imaging of the anterior compartment of the lower leg is a biomarker for weakness, disability, and impaired gait in childhood Charcot-Marie-Tooth disease.
    Cornett KMD; Wojciechowski E; Sman AD; Walker T; Menezes MP; Bray P; Halaki M; Burns J;
    Muscle Nerve; 2019 Feb; 59(2):213-217. PubMed ID: 30265406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fat mass rather than muscle strength is the major determinant of physical function and disability in postmenopausal women younger than 75 years of age.
    Lebrun CE; van der Schouw YT; de Jong FH; Grobbee DE; Lamberts SW
    Menopause; 2006; 13(3):474-81. PubMed ID: 16735945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A.
    Padua L; Shy ME; Aprile I; Cavallaro T; Pareyson D; Quattrone A; Rizzuto N; Vita G; Tonali P; Schenone A
    J Peripher Nerv Syst; 2008 Mar; 13(1):64-70. PubMed ID: 18346232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treadmill training in patients affected by Charcot-Marie-Tooth neuropathy: results of a multicenter, prospective, randomized, single-blind, controlled study.
    Mori L; Signori A; Prada V; Pareyson D; Piscosquito G; Padua L; Pazzaglia C; Fabrizi GM; Picelli A; Schenone A;
    Eur J Neurol; 2020 Feb; 27(2):280-287. PubMed ID: 31444929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Balance and muscle power of children with Charcot-Marie-Tooth.
    Silva TR; Testa A; Baptista CR; Marques W; Mattiello-Sverzut AC
    Braz J Phys Ther; 2014; 18(4):334-42. PubMed ID: 25076001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physical function and performance measures of children and adolescents with Charcot-Marie-Tooth disease.
    Baptista CR; Nascimento-Elias AH; Garcia B; Testa A; Domingues PC; Martinez EZ; Marques W; Mattiello-Sverzut AC
    Physiother Theory Pract; 2021 Jan; 37(1):73-80. PubMed ID: 31046526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility and Preliminary Efficacy of a 10-Week Resistance and Aerobic Exercise Intervention During Neoadjuvant Chemoradiation Treatment in Rectal Cancer Patients.
    Singh F; Galvão DA; Newton RU; Spry NA; Baker MK; Taaffe DR
    Integr Cancer Ther; 2018 Sep; 17(3):952-959. PubMed ID: 29888608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors that influence health-related quality of life in Australian adults with Charcot-Marie-Tooth disease.
    Redmond AC; Burns J; Ouvrier RA
    Neuromuscul Disord; 2008 Aug; 18(8):619-25. PubMed ID: 18656353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Muscle quality, aerobic fitness and fat mass predict lower-extremity physical function in community-dwelling older adults.
    Misic MM; Rosengren KS; Woods JA; Evans EM
    Gerontology; 2007; 53(5):260-6. PubMed ID: 17446711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Muscle strength can better differentiate between gradations of functional performance than muscle quality in healthy 50-70y women.
    Francis P; McCormack W; Toomey C; Lyons M; Jakeman P
    Braz J Phys Ther; 2017; 21(6):457-464. PubMed ID: 28709586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sarcopenia and body composition in diabetic Charcot osteoarthropathy.
    Jansen RB; Christensen TM; Bülow J; Rørdam L; Holstein PE; Svendsen OL
    J Diabetes Complications; 2015; 29(7):937-42. PubMed ID: 26139557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fat fraction distribution in lower limb muscles of patients with CMT1A: A quantitative MRI study.
    Bas J; Ogier AC; Le Troter A; Delmont E; Leporq B; Pini L; Guye M; Parlanti A; Lefebvre MN; Bendahan D; Attarian S
    Neurology; 2020 Apr; 94(14):e1480-e1487. PubMed ID: 31980579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
    Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW
    Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Foot Function Index: A Promising Questionnaire for Individuals With Charcot-Marie-Tooth Disease Type 1A.
    Bihel L; Reynaud V; Givron P; Clavelou P; Cornut-Chauvinc C; Pereira B; Thomas E; Taithe F; Coudeyre E
    Arch Phys Med Rehabil; 2019 Dec; 100(12):2403-2406. PubMed ID: 31255638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lower limb manual muscle testing in the early stages of Charcot-Marie-Tooth disease type 1A.
    Vinci P; Serrao M; Pierelli F; Sandrini G; Santilli V
    Funct Neurol; 2006; 21(3):159-63. PubMed ID: 17049135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The motor function measure to study limitation of activity in children and adults with Charcot-Marie-Tooth disease.
    Allard L; Rode G; Jacquin-Courtois S; Pouget MC; Rippert P; Hamroun D; Poirot I; Bérard C; Vuillerot C;
    Ann Phys Rehabil Med; 2014 Dec; 57(9-10):587-99. PubMed ID: 25311851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
    Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
    J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of life.
    Padua L; Pazzaglia C; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G;
    Eur J Neurol; 2016 Aug; 23(8):1343-50. PubMed ID: 27160471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determinants of walking function after stroke: differences by deficit severity.
    Patterson SL; Forrester LW; Rodgers MM; Ryan AS; Ivey FM; Sorkin JD; Macko RF
    Arch Phys Med Rehabil; 2007 Jan; 88(1):115-9. PubMed ID: 17207686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postural stabilization and balance assessment in Charcot-Marie-Tooth 1A subjects.
    Lencioni T; Rabuffetti M; Piscosquito G; Pareyson D; Aiello A; Di Sipio E; Padua L; Stra F; Ferrarin M
    Gait Posture; 2014 Sep; 40(4):481-6. PubMed ID: 25082324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.